fda bpc 157 category 2 bulk drug substances compounding list Peptide Reclassification 2026: What It Means for Providers The Food and Drug Administration's

The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link Updated 2026 FDA Category 2 peptide list As the science and regulations continue to develop, it's important to work with providers who stay informed and prioritize safe, medically guided protocols. At The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this Pharmacy Purchasing & Products Magazine

SKU: 98891919497 · From iglepidom.org